The device aims to eliminate the need for multiple blood draws at clinics, enabling women undergoing IVF to monitor hormone levels from home conveniently.

That gap between the evidence and the rhetoric raises an obvious question: what else might be driving these decisions?

The move follows an earlier allocation of 100 medical places focused on primary care that commenced this year across 10 Australian universities.

The programme is expected to begin with disciplines including physics, chemistry, biotechnology and data science.

Preclinical studies conducted by the company have shown promising results in restoring corneal clarity and function in laboratory and animal models.

President Donald Trump characterised the plan as “a historic $300 billion deal” and thanked Reliance for what he described as a major investment in the project.

The collaboration is part of a broader effort to enhance academic mobility and strengthen educational ties between Australia and India.

The project was led by researchers from Australia’s national science agency, CSIRO, working with the Indian Institute of Science and industry partners including RESCONS Solutions Pvt. Ltd. and Jindal Steel and Power.

“No woman or girl should be caught without pads and tampons when they need them.”

Academic mobility is key component of the agreement, with plans to facilitate doctoral, postdoctoral and faculty exchanges, including joint PhD programs and visiting scholar opportunities.